As of April 7, 2022, 416 people in Singapore were hospitalized due to COVID-19. Out of these, 44 cases required oxygen supplementation, while 15 in the ICU. To date, 1,290 deaths have so far been attributed to COVID-19.
State of the coronavirus (COVID-19) pandemic in Singapore As of February 2, 2022, Singapore had registered more than 362 thousand confirmed cases of COVID-19. Despite having an 88 percent COVID-19 vaccination rate, the country has been going through a surge in COVID-19 infections now caused by the highly-contagious Omicron variant. This has led to delays in its plans to reopen the country for a 'return to normal'.
Gradual return to normalcy? Due to the current increase in COVID-19 infections, Singapore has pushed back plans to remove the restrictions imposed to control the pandemic, with the Prime Minister estimating that it would be another three to six months before the 'new normal' could begin. This was to prevent the healthcare system from being overstressed. While vaccination rates remain high, hospitalization rates have increased, with the majority of those hospitalized being unvaccinated.
Singapore is currently one out of more than 200 countries and territories battling the novel coronavirus. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
As of April 7, 2022, the total number of COVID-19 cases in Singapore amounted to around 1.1 million. There has been a decrease in daily cases in Singapore this week, though the number is still expected to rise largely due to the highly-contagious Omicron variant.
Overcoming the COVID-19 pandemic Singapore was one of the few countries worldwide that had managed to successfully control the spread of COVID-19. This was done through imposing a strict lockdown period during the beginning of the pandemic in 2020, introducing and enforcing hygiene and social-distancing rules, and effective contact tracing, among others. The measures in place had the intended impact, as the number of daily recorded cases have decreased to manageable levels. Furthermore, community transmission has been reduced to just several cases a week; the majority of the daily new cases of COVID-19 recorded were from overseas arrivals.
Recovering from the economic impact of COVID-19 The closure of businesses, compounded by the global restrictions on movement, had had an adverse effect on its economy. Singapore went through its worse recession on record, while the resident unemployment rate increased. However, with restrictions in the country easing, economists have raised their forecasts for economic growth in Singapore for 2021.
Singapore is currently one out of more than 200 countries and territories battling the novel coronavirus. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Singapore recorded 2414394 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, Singapore reported 1722 Coronavirus Deaths. This dataset includes a chart with historical data for Singapore Coronavirus Cases.
On November 4, 2022, Singapore recorded 3,128 new confirmed cases of COVID-19. Although the number of daily cases is started to decline, Singapore is still expecting a rise in cases caused by the highly-contagious Omicron variant.
Singapore is currently one out of more than 200 countries and territories battling the novel coronavirus. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
After three years of around-the-clock tracking of COVID-19 data from around the world, Johns Hopkins has discontinued the Coronavirus Resource Center’s operations.
The site’s two raw data repositories will remain accessible for information collected from 1/22/20 to 3/10/23 on cases, deaths, vaccines, testing and demographics.
Novel Corona Virus (COVID-19) epidemiological data since 22 January 2020. The data is compiled by the Johns Hopkins University Center for Systems Science and Engineering (JHU CCSE) from various sources including the World Health Organization (WHO), DXY.cn, BNO News, National Health Commission of the People’s Republic of China (NHC), China CDC (CCDC), Hong Kong Department of Health, Macau Government, Taiwan CDC, US CDC, Government of Canada, Australia Government Department of Health, European Centre for Disease Prevention and Control (ECDC), Ministry of Health Singapore (MOH), and others. JHU CCSE maintains the data on the 2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository on Github.
Fields available in the data include Province/State, Country/Region, Last Update, Confirmed, Suspected, Recovered, Deaths.
On 23/03/2020, a new data structure was released. The current resources for the latest time series data are:
---DEPRECATION WARNING---
The resources below ceased being updated on 22/03/2020 and were removed on 26/03/2020:
JHU Coronavirus COVID-19 Global Cases, by country
PHS is updating the Coronavirus Global Cases dataset weekly, Monday, Wednesday and Friday from Cloud Marketplace.
This data comes from the data repository for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). This database was created in response to the Coronavirus public health emergency to track reported cases in real-time. The data include the location and number of confirmed COVID-19 cases, deaths, and recoveries for all affected countries, aggregated at the appropriate province or state. It was developed to enable researchers, public health authorities and the general public to track the outbreak as it unfolds. Additional information is available in the blog post.
Visual Dashboard (desktop): https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Included Data Sources are:
%3C!-- --%3E
**Terms of Use: **
This GitHub repo and its contents herein, including all data, mapping, and analysis, copyright 2020 Johns Hopkins University, all rights reserved, is provided to the public strictly for educational and academic research purposes. The Website relies upon publicly available data from multiple sources, that do not always agree. The Johns Hopkins University hereby disclaims any and all representations and warranties with respect to the Website, including accuracy, fitness for use, and merchantability. Reliance on the Website for medical guidance or use of the Website in commerce is strictly prohibited.
**U.S. county-level characteristics relevant to COVID-19 **
Chin, Kahn, Krieger, Buckee, Balsari and Kiang (forthcoming) show that counties differ significantly in biological, demographic and socioeconomic factors that are associated with COVID-19 vulnerability. A range of publicly available county-specific data identifying these key factors, guided by international experiences and consideration of epidemiological parameters of importance, have been combined by the authors and are available for use:
https://data.gov.sg/open-data-licencehttps://data.gov.sg/open-data-licence
Dataset from Ministry of Health. For more information, visit https://data.gov.sg/datasets/d_abeeab6fb3b739d7b234e7452bafd07c/view
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team, except for aggregation of individual case count data into daily counts when that was the best data available for a disease and location. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretability. We also formatted the data into a standard data format. All geographic locations at the country and admin1 level have been represented at the same geographic level as in the data source, provided an ISO code or codes could be identified, unless the data source specifies that the location is listed at an inaccurate geographical level. For more information about decisions made by the curation team, recommended data processing steps, and the data sources used, please see the README that is included in the dataset download ZIP file.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This is the data for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). Also, Supported by ESRI Living Atlas Team and the Johns Hopkins University Applied Physics Lab (JHU APL).Data SourcesWorld Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus
https://github.com/disease-sh/API/blob/master/LICENSEhttps://github.com/disease-sh/API/blob/master/LICENSE
In past 24 hours, Singapore, Asia had N/A new cases, N/A deaths and N/A recoveries.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This is the data for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). Also, Supported by ESRI Living Atlas Team and the Johns Hopkins University Applied Physics Lab (JHU APL).Data SourcesWorld Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Gegevens voor het "2019 Novel Coronavirus Visual Dashboard" beheerd door "the Johns Hopkins University Center for Systems Science and Engineering" (JHU CSSE). Ook ondersteund door het "ESRI Living Atlas Team" en het "Johns Hopkins University Applied Physics Lab" (JHU APL).Gegevensbronnen:World Health Organization (WHO): https://www.who.int/ DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia. BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/ National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0 US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-casesMinistry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus
Background The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear. In Singapore, extensive contact tracing by the Ministry of Health for every diagnosed COVID-19 case, and legally enforced quarantine and intensive health surveillance of close contacts provided a rare opportunity to determine asymptomatic attack rates and SARS-CoV-2 transmission risk factors among community close contacts of patients with COVID-19. Methods This retrospective cohort study involved all close contacts of confirmed COVID-19 cases in Singapore, identified between Jan 23 and April 3, 2020. Household contacts were defined as individuals who shared a residence with the index COVID-19 case. Non-household close contacts were defined as those who had contact for at least 30 min within 2 m of the index case. All patients with COVID-19 in Singapore received inpatient treatment, with access restricted to health-care staff. All close contacts were quarantined for 14 days with thrice-daily symptom monitoring via telephone. Symptomatic contacts underwent PCR testing for SARS-CoV-2. Secondary clinical attack rates were derived from the prevalence of PCR-confirmed SARS-CoV-2 among close contacts. Consenting contacts underwent serology testing and detailed exposure risk assessment. Bayesian modelling was used to estimate the prevalence of missed diagnoses and asymptomatic SARS-CoV-2-positive cases. Univariable and multivariable logistic regression models were used to determine SARS-CoV-2 transmission risk factors. Findings Between Jan 23 and April 3, 2020, 7770 close contacts (1863 household contacts, 2319 work contacts, and 3588 social contacts) linked to 1114 PCR-confirmed index cases were identified. Symptom-based PCR testing detected 188 COVID-19 cases, and 7582 close contacts completed quarantine without a positive SARS-CoV-2 PCR test. Among 7518 (96·8%) of the 7770 close contacts with complete data, the secondary clinical attack rate was 5·9% (95% CI 4·9-7·1) for 1779 household contacts, 1·3% (0·9-1·9) for 2231 work contacts, and 1·3% (1·0-1·7) for 3508 social contacts. Bayesian analysis of serology and symptom data obtained from 1150 close contacts (524 household contacts, 207 work contacts, and 419 social contacts) estimated that a symptom-based PCR-testing strategy missed 62% (95% credible interval 55-69) of COVID-19 diagnoses, and 36% (27-45) of individuals with SARS-CoV-2 infection were asymptomatic. Sharing a bedroom (multivariable odds ratio [OR] 5·38 [95% CI 1·82-15·84]; p=0·0023) and being spoken to by an index case for 30 min or longer (7·86 [3·86-16·02]; p<0·0001) were associated with SARS-CoV-2 transmission among household contacts. Among non-household contacts, exposure to more than one case (multivariable OR 3·92 [95% CI 2·07-7·40], p<0·0001), being spoken to by an index case for 30 min or longer (2·67 [1·21-5·88]; p=0·015), and sharing a vehicle with an index case (3·07 [1·55-6·08]; p=0·0013) were associated with SARS-CoV-2 transmission. Among both household and non-household contacts, indirect contact, meal sharing, and lavatory co-usage were not independently associated with SARS-CoV-2 transmission. Interpretation Targeted community measures should include physical distancing and minimising verbal interactions. Testing of all household contacts, including asymptomatic individuals, is warranted. Funding Ministry of Health of Singapore, National Research Foundation of Singapore, and National Natural Science Foundation of China.
As of March 25, 2020, the largest age group among Singaporeans confirmed to have COVID-19 were those between 20 to 29 years old, with 141 such cases. These were mostly Singaporeans who had returned from their studies or travels overseas, especially Europe and North America. At the time of writing, Singapore is experiencing a second wave of novel coronavirus infections. This was mostly brought into the country from returning Singapore citizens and residents.
A survey conducted on Singaporeans during the COVID-19 pandemic found that the share of respondents who rated the government's performance as excellent decreased in April 2020. Singapore started seeing an surge in COVID-19 cases beginning in late March, and currently has over 11 thousand cases, the highest in Southeast Asia.
Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
The difficulties of death figures
This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
In 2022, there was a total of 2,511 reported cases of tuberculosis in Singapore. This was an increase in tuberculosis cases compared to the ones reported in the previous year, which was 2,314 cases.
In 2022, there was four reported cases of measles in Singapore. This was a steep decrease in comparison to the cases reported in the previous years. The decline in the measles cases in Singapore in that year was likely due to the social distancing measures implemented during the COVID-19 pandemic, as well as Singapore's high rate of measles vaccinations.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
As of April 7, 2022, 416 people in Singapore were hospitalized due to COVID-19. Out of these, 44 cases required oxygen supplementation, while 15 in the ICU. To date, 1,290 deaths have so far been attributed to COVID-19.
State of the coronavirus (COVID-19) pandemic in Singapore As of February 2, 2022, Singapore had registered more than 362 thousand confirmed cases of COVID-19. Despite having an 88 percent COVID-19 vaccination rate, the country has been going through a surge in COVID-19 infections now caused by the highly-contagious Omicron variant. This has led to delays in its plans to reopen the country for a 'return to normal'.
Gradual return to normalcy? Due to the current increase in COVID-19 infections, Singapore has pushed back plans to remove the restrictions imposed to control the pandemic, with the Prime Minister estimating that it would be another three to six months before the 'new normal' could begin. This was to prevent the healthcare system from being overstressed. While vaccination rates remain high, hospitalization rates have increased, with the majority of those hospitalized being unvaccinated.
Singapore is currently one out of more than 200 countries and territories battling the novel coronavirus. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.